Germline DDX41 mutations define a significant entity within adult MDS/AML patients

M Sébert, M Passet, A Raimbault… - Blood, The Journal …, 2019 - ashpublications.org
Germline DDX41 mutations are involved in familial myelodysplastic syndromes (MDSs) and
acute myeloid leukemias (AMLs). We analyzed the prevalence and characteristics of DDX41 …

The clinical spectrum, diagnosis, and management of GATA2 deficiency

M Santiago, A Liquori, E Such, Á Zúñiga, J Cervera - Cancers, 2023 - mdpi.com
Simple Summary A predisposition to myeloid neoplasms has recently been recognized as a
defined clinical entity by the World Health Organization. One of the most well-known …

The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants

A Rio-Machin, T Vulliamy, N Hug, A Walne… - Nature …, 2020 - nature.com
The inclusion of familial myeloid malignancies as a separate disease entity in the revised
WHO classification has renewed efforts to improve the recognition and management of this …

AML through the prism of molecular genetics

S Charrot, H Armes, A Rio‐Machin… - British journal of …, 2020 - Wiley Online Library
Modern management of acute myeloid leukaemia (AML) relies on the integration of
phenotypic and genetic data to assign classification, establish prognosis, enhance …

Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms

HB Alkhateeb, A Nanaa, D Viswanatha… - Blood …, 2022 - ashpublications.org
DDX41 mutations (germline and somatic) are associated with late onset myelodysplastic
syndromes/acute myeloid leukemia (MDS/AML). Myeloid neoplasms (MN) with germline …

[HTML][HTML] Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies

GW Roloff, LA Godley, MW Drazer - Genetics in Medicine, 2021 - Elsevier
Purpose To determine the degree of testing consistency among commercially available
diagnostic assays for hereditary hematopoietic malignancies (HHMs). Methods Next …

Diagnostic challenge and clinical dilemma: the long reach of clonal hematopoiesis

A Osman, JL Patel - Clinical Chemistry, 2021 - academic.oup.com
Background Widespread application of massively parallel sequencing has resulted in
recognition of clonal hematopoiesis in various clinical settings and on a relatively frequent …

Comparison between GATA2 and DDX41-mutated myeloid neoplasms

A Nanaa, R He, D Viswanatha… - Leukemia …, 2022 - pubmed.ncbi.nlm.nih.gov
Comparison between GATA2 and DDX41-mutated myeloid neoplasms Comparison between
GATA2 and DDX41-mutated myeloid neoplasms Leuk Res. 2022 Oct:121:106931. doi …

Heterozygous loss of Srp72 in mice is not associated with major hematological phenotypes

T D'Altri, MB Schuster, A Wenzel… - European Journal of …, 2019 - Wiley Online Library
Objectives Familial cases of hematological malignancies are associated with germline
mutations. In particular, heterozygous mutations of SRP72 correlate with the development of …

Evaluation of miR-143 rs4705342 and miR-222 rs2858060 genetic variants in patients with acute myeloid leukemia

R Mehrpour, L Kohan, MJ Mokhtari - Human Gene, 2022 - Elsevier
Background and aim Considering the importance of miR-143 and miR-222 in
carcinogenicity and the importance of miRSNPs in acute myeloid leukemia, this research …